Adimab & Adagio Therapeutics
Laura M. Walker is the Sr. Director of Antibody Sciences at Adimab and the Chief Scientific Officer at Adagio Therapeutics, Inc. Her team at Adimab is focused on understanding human B cell responses to viral infection and discovering broadly cross-reactive neutralizing antibodies to a wide variety of emerging viral pathogens, including Ebola, Zika, yellow fever, and SARS-CoV-2. At Adagio Therapeutics, Laura oversees a broad portfolio of research in the area of viral immunology, including the identification of potent neutralizing antibodies to advance into clinical development. Prior to joining Adimab in 2012, Laura earned her Ph.D. in Immunology and Microbiology at The Scripps Research Institute and completed a post-doctoral research fellowship in Immunology at The University of California-San Francisco.